COVID-19: Vaccines and Therapeutics
Armed with his guitar, a physician has been entertaining people getting their shots at the Mary Washington Healthcare COVID-19 vaccine clinic.
Effective immediately, Medicare will pay $750 to administer monoclonal antibodies to COVID-19 patients in their residence or temporary lodging and increase payment to administer them in most other care settings to $450 from $310 to better align payment with provider costs, the Centers for Medicare…
The Centers for Disease Control’s independent advisory committee will meet May 12 for what’s expected to be a discussion of Pfizer’s request to authorize the emergency use of its COVID-19 vaccine on children aged 12 to 15.
In this AHA video for Mother’s Day, part of AHA’s #MyWhy social media campaign, a pregnant health care worker explains why she chose to get vaccinated.
Moderna Inc. told investors today that is intends to soon file for full Food and Drug Administration approval for its COVID-19 vaccine. Moderna, whose vaccine was authorized for emergency use in December for individuals age 18 and older, said its trial data shows that its vaccine is 96% effective…
On May 5, Dr. James Madara, the AMA’s chief executive officer and executive vice president spoke with AHA’s Rick Pollack, president and chief executive officer, about prioritizing medical justice to address health equity, health care post-pandemic and strategies to increase the numbers of people…
The American Medical Association announced Current Procedural Terminology codes for reporting the two-dose Novavax COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency use.
The Health Resources and Services Administration will provide nearly $1 billion to small rural hospitals, critical access hospitals and rural health clinics to expand COVID-19 testing and help mitigate the virus in their communities, the Department of Health and Human Services announced.
Recorded Wednesday, May 26, 12pm ET
Pfizer Inc. said during its quarterly earnings call that it will file by the end of May for full Food and Drug Administration approval for its COVID-19 vaccine. More than 131 million doses of the Pfizer vaccine have been administered in the U.S. since it was authorized for emergency use in December…